Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914972444> ?p ?o ?g. }
- W2914972444 abstract "289 Background: PDAC has limited treatment options. Genomic analyses have led to development of targeted therapies now in several clinical trials, and may enable the discovery of new treatment options. However, biopsy often yields limited tissue, thus hampering tissue-based profiling opportunities. Data regarding circulating tumor DNA (ctDNA) profiling in PDAC during real time clinical practice is limited. Methods: We performed ctDNA NGS analysis in pts with advanced PDAC (December 2014–August 2018). ctDNA analysis was performed using Guardant 360 (Guardant Health, CA), which detects single nucleotide variants, amplifications, fusions, and specific insertion/deletion mutations in up to 73 different genes. The mutant allele fraction (MAF) for detected alterations was calculated relative to wild type in ctDNA. Therapeutic relevance (TR) was defined as possible treatments within OncoKB levels 1-3B and R1. The study was conducted in accordance with Mayo Clinic Institutional Review Board requirements. Results: Among 171 pts and 206 total samples, ctDNA NGS revealed at least one genomic alteration in 150 pts (88%). Median number of alterations per patient was 3 [range, 1-15]. The total number of unique alterations was 450 with the most commonly altered genes being: TP53 (181 alterations, 40%), followed by KRAS (118 alterations, 26%), CDKN2A (23 alterations, 5%), SMAD4 (15 alterations, 3%), EGFR (11 alterations, 2.4%), PIK3CA (9 alterations, 2%), GNAS (8 alterations, 1.5%). Amplifications were noted in 16 genes, including BRAF, CCND2, CCNE1, CDK4, CDK6, EGFR, ERBB2, FGFR1, FGFR2, KIT, KRAS, MET, MYC, PDGFRA, PIK3CA and RAF1. Therapeutically relevant alterations were seen in 95 pts of the 150 pts (63%). Tissue based profiling (Results to be shown) was done in 56 (33%) pts of total 171 pts with a median of 130 days between ctDNA and tissue biopsy. KRAS and TP53 were the most common gene mutations found in patients with both liquid and tissue biopsy results. Conclusions: ctDNA plasma profiling of pts with advanced PDAC is a feasible alternative method to gather comprehensive genomic data." @default.
- W2914972444 created "2019-02-21" @default.
- W2914972444 creator A5002142386 @default.
- W2914972444 creator A5018085097 @default.
- W2914972444 creator A5018257387 @default.
- W2914972444 creator A5019011169 @default.
- W2914972444 creator A5043086563 @default.
- W2914972444 creator A5050862493 @default.
- W2914972444 creator A5062280376 @default.
- W2914972444 creator A5063534090 @default.
- W2914972444 creator A5064791048 @default.
- W2914972444 creator A5074891676 @default.
- W2914972444 creator A5076608390 @default.
- W2914972444 creator A5077416215 @default.
- W2914972444 creator A5089382639 @default.
- W2914972444 date "2019-02-01" @default.
- W2914972444 modified "2023-10-14" @default.
- W2914972444 title "Landscape of circulating tumor DNA profiling of advanced pancreatic cancer (PDAC)." @default.
- W2914972444 doi "https://doi.org/10.1200/jco.2019.37.4_suppl.289" @default.
- W2914972444 hasPublicationYear "2019" @default.
- W2914972444 type Work @default.
- W2914972444 sameAs 2914972444 @default.
- W2914972444 citedByCount "0" @default.
- W2914972444 crossrefType "journal-article" @default.
- W2914972444 hasAuthorship W2914972444A5002142386 @default.
- W2914972444 hasAuthorship W2914972444A5018085097 @default.
- W2914972444 hasAuthorship W2914972444A5018257387 @default.
- W2914972444 hasAuthorship W2914972444A5019011169 @default.
- W2914972444 hasAuthorship W2914972444A5043086563 @default.
- W2914972444 hasAuthorship W2914972444A5050862493 @default.
- W2914972444 hasAuthorship W2914972444A5062280376 @default.
- W2914972444 hasAuthorship W2914972444A5063534090 @default.
- W2914972444 hasAuthorship W2914972444A5064791048 @default.
- W2914972444 hasAuthorship W2914972444A5074891676 @default.
- W2914972444 hasAuthorship W2914972444A5076608390 @default.
- W2914972444 hasAuthorship W2914972444A5077416215 @default.
- W2914972444 hasAuthorship W2914972444A5089382639 @default.
- W2914972444 hasConcept C104317684 @default.
- W2914972444 hasConcept C120821319 @default.
- W2914972444 hasConcept C121608353 @default.
- W2914972444 hasConcept C126322002 @default.
- W2914972444 hasConcept C141231307 @default.
- W2914972444 hasConcept C143998085 @default.
- W2914972444 hasConcept C166608930 @default.
- W2914972444 hasConcept C16930146 @default.
- W2914972444 hasConcept C190283241 @default.
- W2914972444 hasConcept C2775922572 @default.
- W2914972444 hasConcept C2777609662 @default.
- W2914972444 hasConcept C2779529041 @default.
- W2914972444 hasConcept C2780210213 @default.
- W2914972444 hasConcept C2780265364 @default.
- W2914972444 hasConcept C2781187634 @default.
- W2914972444 hasConcept C37307934 @default.
- W2914972444 hasConcept C502942594 @default.
- W2914972444 hasConcept C526805850 @default.
- W2914972444 hasConcept C54355233 @default.
- W2914972444 hasConcept C60644358 @default.
- W2914972444 hasConcept C71924100 @default.
- W2914972444 hasConcept C74231797 @default.
- W2914972444 hasConcept C86554907 @default.
- W2914972444 hasConcept C86803240 @default.
- W2914972444 hasConceptScore W2914972444C104317684 @default.
- W2914972444 hasConceptScore W2914972444C120821319 @default.
- W2914972444 hasConceptScore W2914972444C121608353 @default.
- W2914972444 hasConceptScore W2914972444C126322002 @default.
- W2914972444 hasConceptScore W2914972444C141231307 @default.
- W2914972444 hasConceptScore W2914972444C143998085 @default.
- W2914972444 hasConceptScore W2914972444C166608930 @default.
- W2914972444 hasConceptScore W2914972444C16930146 @default.
- W2914972444 hasConceptScore W2914972444C190283241 @default.
- W2914972444 hasConceptScore W2914972444C2775922572 @default.
- W2914972444 hasConceptScore W2914972444C2777609662 @default.
- W2914972444 hasConceptScore W2914972444C2779529041 @default.
- W2914972444 hasConceptScore W2914972444C2780210213 @default.
- W2914972444 hasConceptScore W2914972444C2780265364 @default.
- W2914972444 hasConceptScore W2914972444C2781187634 @default.
- W2914972444 hasConceptScore W2914972444C37307934 @default.
- W2914972444 hasConceptScore W2914972444C502942594 @default.
- W2914972444 hasConceptScore W2914972444C526805850 @default.
- W2914972444 hasConceptScore W2914972444C54355233 @default.
- W2914972444 hasConceptScore W2914972444C60644358 @default.
- W2914972444 hasConceptScore W2914972444C71924100 @default.
- W2914972444 hasConceptScore W2914972444C74231797 @default.
- W2914972444 hasConceptScore W2914972444C86554907 @default.
- W2914972444 hasConceptScore W2914972444C86803240 @default.
- W2914972444 hasLocation W29149724441 @default.
- W2914972444 hasOpenAccess W2914972444 @default.
- W2914972444 hasPrimaryLocation W29149724441 @default.
- W2914972444 hasRelatedWork W2366853320 @default.
- W2914972444 hasRelatedWork W2370826676 @default.
- W2914972444 hasRelatedWork W2894606073 @default.
- W2914972444 hasRelatedWork W2914972444 @default.
- W2914972444 hasRelatedWork W2972351380 @default.
- W2914972444 hasRelatedWork W3090004306 @default.
- W2914972444 hasRelatedWork W3210107282 @default.
- W2914972444 hasRelatedWork W3211933472 @default.
- W2914972444 hasRelatedWork W4283767552 @default.
- W2914972444 hasRelatedWork W4288497676 @default.
- W2914972444 isParatext "false" @default.
- W2914972444 isRetracted "false" @default.